Soligenix, Inc. (NASDAQ:SNGX) closed with change of -11.97% to $1.03 with the total traded volume of 398557 shares versus to an average volume of 52.91K. The stock was down in the 5 days activity -29.45%. The one month performance of stock was -29.45%. SNGX shares are at -47.72% for the quarter and driving a -50.95% return over the course of the past year and is now at -53.59% since this point in 2018. 19 employees work in the Company. It has market cap of $10.46M
Right now SNGX beta is 0.38. The average volatility for the week and month was at 14.72% 6.59% respectively. There are 10.16M shares outstanding and 7.53M shares are floated in market.
Soligenix, Inc. (NASDAQ:SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, reported the pricing of an underwritten public offering of 7,766,990 shares of its common stock and warrants to purchase 3,106,796 shares of common stock at a combined public offering price of $1.03 per share and warrant. The warrants will have an initial per share exercise price of $2.25, subject to customary adjustment, are exercisable immediately and will expire forty-two (42) months from the date of issuance. The gross proceeds to Soligenix, Inc. from this offering are expected to be approximately $8,000,000, before deducting underwriting discounts and commissions and other estimated offering expenses.
Soligenix, Inc. has granted the underwriters a 45-day option to purchase up to an additional 1,165,048 shares of common stock and/or additional warrants to purchase up to 466,019 shares of common stock to cover over-allotments, if any. The offering is expected to close on July 2, 2018, subject to customary closing conditions.
The closing price of the Company’s common stock on June 27, 2018, was $1.03 per share on the NASDAQ CM. A.G.P./Alliance Global Partners is acting as the sole book-running manager for the offering.
Shares of Soligenix, Inc. have been recently spotted trading -72.16% off of the 52-week high price. On the other end, company shares have been noted -9.65% away from the low price over the last 52-weeks. 52 week range of the stock remained $ 1.14 – 3.70. Switching over to some distances from popular moving averages, we see that the stock has been recorded -35.18% away from the 50 day moving average and -47.61% away from the 200 day moving average. Moving closer, we can see that shares have been trading -30.23% off of the 20-day moving average.